Tarsus Pharmaceuticals, Inc. (TARS)
NMS – Real vaqt narxi. Valyuta: USD
70.01
+0.56 (0.80%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
70.01
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
70.01
+0.56 (0.80%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
70.01
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $204.6M umumiy qarzdan $88.7M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $562.0M jami joriy majburiyatlardan $175.8M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.3) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-9.2x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Kompaniya ijobiy erkin pul oqimi $57.2M generatsiya qiladi, moliyaviy salomatligini qo'llab-quvvatlaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 3.20 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 3.17 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.26 | 0.30 | 8.0 | |
| Qarz/Aktivlar nisbati | 0.15 | 1.04 | 8.0 | |
| Foiz to‘lov qoplami | -9.23 | -16.91 | 1.0 | |
| O‘rtacha ball | 7.4 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 26M | 17M | 183M | 451M | 606M |
| Yalpi foyda | 25M | 16M | 170M | 421M | 566M |
| Operatsion daromad | -63M | -143M | -121M | -71M | -49M |
| Sof foyda | -62M | -136M | -116M | -66M | -46M |
| EBITDA | -62M | -142M | -119M | -69M | -46M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 51.64 | -423.77 | 5.5 |
| Keyingi chorak | 31.1 | 134.12 | 10 |
| Joriy yil | 57.82 | -24.8 | 5.5 |
| Keyingi yil | 28.9 | 212.05 | 10 |
| O‘rtacha ball | 7.8 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 7.32 | -166.26 | -168.74 | 287.57 | 4.3 |
| Yil/Yil | 69.41 | 8.8 | 10.42 | 288.08 | 8.3 |
| 3 yil o‘rtacha | 354.31 | -20.44 | -0.51 | -12.55 | 3.3 |
| 5 yil o‘rtacha | 401.44 | -72.39 | -38.63 | -317.91 | 3.3 |
| O‘rtacha ball | 4.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |